1 / 3

Bipolar Disorder Market Size & Growth

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on u201cGlobal Bipolar Disorder Market - Forecast to 2026u201d <br>https://www.globalmarketestimates.com/market-report/global-bipolar-disorder-market-3228<br>

Globalestimates
Download Presentation

Bipolar Disorder Market Size & Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Bipolar Disorder Market Size-Forecasts to 2026 As per the research conducted by GME, the Bipolar Disorder Market will grow with a CAGR value of 2.7% by 2026. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Bipolar Disorder Market - Forecast to 2026” https://www.globalmarketestimates.com/market-report/global-bipolar-disorder-market-3228 By Mechanism of Action (Benzodiazepines, Selective serotonin reuptake inhibitor, Serotonin- norepinephrine reuptake inhibitor, Tricyclic antidepressant drugs, Monoamine oxidase inhibitors, Beta- blockers, Others) By Drug Class (Antidepressant drugs, Mood stabilizer, Anticonvulsants, Antianxiety drugs, Antipsychotic drugs) By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis Key Market Insights •Selective serotonin reuptake inhibitors are suggested as the primary line of treatment for the therapy of depression in bipolar disorder as these meds are viewed as effective and safe. •Moreover, flood in the number of patients experiencing bipolar disorder is relied upon to be one of the primary impetuses for the development of the worldwide bipolar disorder therapeutics market during the predicted time frame. •Given the bipolar disorder therapeutics market projections, mood stabilizers are the medications that are suggested and utilized for lessening manic symptoms. •Government assistance and technical developments are also contributing to the global bipolar disorder market's growth in the APAC region •Glaxo SmithKline (GSK), AstraZeneca, Pfizer Inc., Otsuka Holdings Co. Ltd, Janssen Pharmaceuticals, AbbVie Inc., Eli Lilly, Novartis AG, and Allergan Plc. are the top players in the Bipolar Disorder market. Browse the Report @ https://www.globalmarketestimates.com/market-report/global-bipolar-disorder- market-3228 Mechanism of Action Outlook (Revenue, USD Billion, 2021-2026) •Benzodiazepines •Selective serotonin reuptake inhibitor •Serotonin-norepinephrine reuptake inhibitor

  2. •Tricyclic antidepressant drugs •Monoamine oxidase inhibitors •Beta-blockers •Others Drug Class Outlook (Revenue, USD Billion, 2021-2026) •Antidepressant drugs •Mood stabilizer •Anticonvulsants •Antianxiety drugs •Antipsychotic drugs Regional Outlook (Revenue, USD Billion, 2021-2026) North America •The U.S. •Canada •Mexico Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia Pacific •China •India •Japan •South Korea •Australia •Rest of APAC Central & South America

  3. •Brazil •Argentina •Rest of CSA Middle East & Africa •Saudi Arabia •UAE •Rest of MEA Contact: Tracy Simon Email address: tracy.simon@globalmarketestimates.com Phone Number: +16026667238 Website: https://www.globalmarketestimates.com/ Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

More Related